Navigation Links
Population Covered by Dental Benefits Increases
Date:10/23/2007

presenting the entire dental benefits industry. NADP's member dental plans provide dental benefits to more than 136 million of the approximately 170 million Americans with dental benefits.

About DDPA

Delta Dental Plans Association (http://www.deltadental.com) based in Oak Brook, IL, is a national network of independent not-for-profit dental service corporations specializing in providing dental benefits programs to 50 million Americans in more than 88,000 employee groups throughout the country.


'/>"/>
SOURCE National Association of Dental Plans
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Poor health care in Russia maybe causing Decline in its Population
2. Increasing risk of heart failure for ageing population
3. Prime Minister Manmohan Against Incentive-Based Population Control
4. Pigs Population A Major Threat To Encephalitis Ravaged UP
5. Scorecard to help in diabetic risk assessment of the Indian Population
6. Scorecard to help in diabetic risk assessment of the Indian Population
7. Elderly Population’s Sedentary Lifestyle Is Dependant On Their Expectations From Lif
8. Rural Population Enjoys Better Mental Health
9. Prevention And Control Of Diabetes Crucial To Indian Population
10. World population To Be Seven billion in Six Years
11. Drug Controller General to Withdraw Drug that Affects Vulture Population
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...effective against Lennox-Gastaut syndrome , ...ug called Banzel (rufinamide) has been approved as...ilepsy called Lennox-Gastaut syndrome, the U.S. Fo...The approval was based on results of a four-month .... Compared to patients who took a placebo, those w...
(Date:11/21/2008)...PRNewswire-USNewswire/ -- New research at West Vi...s, spitless tobacco product aimed at young adults ...t RJ Reynolds, Camel Snus - touted as a socially a...risingly high levels of nicotine. , , "Came...f products," said Bruce Adkins of the state Divisi...
(Date:11/21/2008)...ewswire-USNewswire/ -- U.S. News & World Repor... (NCQA) ranked BlueChoice(R) HealthPlan of South C...Plans(TM), published in U.S. News & World Repo...ual ranking ranks the nation,s best health plans b...NCQA accreditation scores. NCQA and U.S. News &...
(Date:11/21/2008)...ewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (...s overwhelmingly approved the proposals submitted ...a Pharmaceuticals Industries Ltd. (Nasdaq: TEVA ...whelming support of the transaction by the Barr sh... and CEO. "We are pleased with the progress that w...
Breaking Medicine News(10 mins):Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4
...rganization (NACO) of India plans to promote the d...attle against HIV/AIDS//. The third phase of the N...y to be launched in April. Statistics show that ...the private sector for outpatient care and over 50...
...fusal of surgery to known smokers is all set to be...ating the issue in this week’s BMJ//. The issue wa...t last year to remove smokers from the waiting lis...Peters who is from Concord Repatriation General Ho...
...on therapy on the exterior along with radiation se...highly effective// for treatment of prostate cance...of Radiation Oncology Biology Physics has revealed...undergone such a combination therapy have been com...
...or Disease Control and Prevention (CDC) Atlanta's ...is time the US changed its guidelines// and made T...irrespective of how long they have been residing t...ated if all foreign-born residents from high-risk ...
Other Medicine News:Health News:Refusal of Surgery for Smokers – To Be or Not to Be 2Health News:All Foreign-born Nationals In US To Be Tested For TB 2
(Date:11/21/2008)...England, November 21 , ...an Committee for Medicinal Products for Human Use ...n for the approval of Enbrel(R),(etanercept) as a...,adolescents with severe plaque psoriasis. If appr...mmittee,s recommendation, Enbrel will become the,...
(Date:11/20/2008)... , , PHILADELPHIA, Nov. 20 /PRNewswire-Firs...unced that the United States Food and Drug Adminis...MACTA(R) (eltrombopag) for the treatment of thromb...thic) thrombocytopenic purpura (ITP) who have had ...oglobulins or splenectomy. The approval is a signi...
(Date:11/20/2008)...lif., Nov. 20 Duska Ther...nced today that it has submitted its,pivotal Phas...r a Special,Protocol Assessment (SPA) procedure w..., Subject to securing an agreement with the...tive, double-blind, placebo-controlled and randomi...
(Date:11/19/2008)...O, Nov. 19 Posit Science Corporati...the Society for Neuroscience,Annual Conference in...e,training may benefit Baby Boomers. The compute...m (TM) uses adaptive exercises that target auditor...ed to drive generalized,improvements in cognition...
Breaking Medicine Technology:CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 2CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 3CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 4CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Pregnant mice block out unwelcome admirers to protect their pups 4122 1Pregnant mice block out unwelcome admirers to protect their pups 4122 2Capella University Launches Online PhD Specialization in Nursing Education 24214 1Capella University Launches Online PhD Specialization in Nursing Education 24214 2Capella University Launches Online PhD Specialization in Nursing Education 24214 3Incidence of Mantle Cell Lymphoma on Rise 24211 1Incidence of Mantle Cell Lymphoma on Rise 24211 2Breast Fed Babies Have Fewer GI Infections 24208 1Breast Fed Babies Have Fewer GI Infections 24208 2
...Onset and Total,Sleep Time, and key secondary endp... met at both doses - Evotec to host a,conference c...BURG, Germany | OXFORD, England, June 4, 2007-- Ev...today positive top-line,results from its first pha...hronic primary insomnia. EVT 201 is a partial,posi...
...ebo-controlled Trial,Ever Conducted in CTCL Presen...CHICAGO, June 04, 2007 /PRNewswire/ -- Preliminary...lled clinical trial ever,conducted in patients wit...AK was more than twice as effective as placebo in ...L. [Abstract number 8026],The primary endpoint of ...
Other Medicine Technology:Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 2Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 3Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 4Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 2Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 3Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 4Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 5Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 6
Grafton DBM Matrix PLF is the first bone graft material designed specifically for posterolateral fusion procedures. Unique trough-like design allows for easy use with allograft/autograft bone. Demine
Demineralized bone matrix dispensed in a jar. Fibers will be free of foreign matter. Glycerol 70-88% by weight. Calcium content less than 8%.
Demineralized bone matrix dispensed in a syringe. DBM will be free of foreign matter. Demineralized bone matrix particle size 125 to 850 . Glycerol 70-88% by weight. Calcium content less than 8%.
Inductive demineralized bone matrix and conductive cancellous chips. DBM and cancellous chips will be free of foreign matter. Demineralized bone matrix particle size is 125 to 1000 . Cancellous chip
Medicine Products: